|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||45.32 - 46.53|
|52 Week Range||30.87 - 51.50|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Several IPO stocks have been on a tear lately as innovative products fuel booming sales. Most aren't profitable, but Wall Street doesn't seem to mind.
An IPO that happened on Thursday, a filing for another one, and more than $600 million in funding tops the Bay Area's venture news heading into the holiday weekend.
All six have doubled in value — or more — since their Wall Street debuts and they are either headquartered in the Bay Area or backed by investors from the region.
A South San Francisco biotech's offering soared on Thursday, but a San Mateo ruggedized smartphone maker's priced well below its targets. Here's more on that and other Bay Area founder and funder news at the end of the week.
Beyond Meat’s reliance on co-manufactures and related disputes with former manufacturing partners point to a potential risk for a company that just had the best first-day IPO of the year.
The measure of the health of the venture and startup world has dropped for two straight quarters now, down from 17-year highs by about 15 percent.
The company joins joins what could be a busy month for Bay Area IPOs in May, which is expected to include Uber's massive offering, Slack's direct listing and the market debut of South San Francisco biotech Cortexyme.
Another unicorn is lining up an IPO for later this year and 10 Bay Area companies raised about $175 million in funding at week's end. Here are the details.
Shares of the Silk Road Medical IPO jumped 80.9% on the first day of trading, with an initial public offering that drew heavy interest from investors for the medical device company.
Shares of Silk Road Medical Inc. soared in their public debut Thursday, enough to pace all gainers on the major U.S. exchanges. The first trade was at $33.15, or 66% above the $20 initial public offering price, at 11:36 a.m. Eastern. Since then, the stock has traded in a range of $32.73 to $37.30, and was recently 85% above its IPO price at $36.96. The medical device company sold 6 million shares in the IPO to raise $120 million, and could raise up to $138 million if the underwriters exercise all the options granted to buy additional shares. At the IPO price, the company was valued at $604.2 million. The IPO priced at the top of the expected range of $19 to $20, up from original expectations of $15 to $17, when the company said it has expected to offer 4.7 million shares for sale. The company went public at a time that the Renaissance IPO ETF has run up 32% year to date, while the S&P 500 has gained 15%.
Silk Road Medical Inc will hit the Nasdaq under ticker SILK on Thursday. Here’s what you should know before making a bid. The Offering Silk Road said it would issue nearly 4.7 million shares between $15 ...
The Silk Road Medical IPO priced at 20 a share, at the high end of its expected range, after one IPO research firm gave the offering its highest rating.
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Ruhnn Holding Ltd (RUHN) will issue 10 million shares between $11.50 ...